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Introduction
Hemorrhagic complications in patients on hemodial-
ysis have been described in many anatomic locations.
Uremic bleeding is associated with uremic toxins,
anemia, platelet dysfunction, use of antiplatelet or anti-
coagulant agents, comorbid conditions and aging.
Hemorrhagic cholecystitis is uncommon but can be
fatal. In addition, hepatobiliary pathology is common
in hemodialysis patients, including acute or chronic
hepatitis, gall stones, and gallbladder carcinoma.1,2
Hemorrhagic cholecystitis is easily overlooked since
its symptoms mimic those of common hepatobiliary
diseases with right upper quadrant abdominal pain,
liver function impairment, leukocytosis and positive
Murphy’s sign. Abdominal ultrasound (US) and com-
puted tomography (CT) can help diagnose and dem-
onstrate the characteristic findings of wall thickening
of the distended gallbladder and heterogeneous mate-
rials inside. Here, we report a hemodialysis patient who
suffered from spontaneous gallbladder hemorrhage
and discuss the possible mechanisms of the disease.
Case Report
An 81-year-old Chinese male presented in 2007 with
end-stage renal failure as a consequence of diabetic
nephropathy and started regular hemodialysis thrice
weekly at an outpatient hemodialysis facility in Taipei
County. He was admitted to our nephrology section
for chronic obstructive pulmonary disease with acute
exacerbation and secondary bacterial lung infection.
On admission, he was treated with bronchodilator
inhalation, intravenous steroid and empirical antibiotic
(cefuroxime).
Unfortunately, repeated frequent attacks of right
upper quadrant abdominal pain developed during he-
modialysis sessions 1 week later. The abdominal pain
resolved soon after the immediate cessation of dialysis.
Physical examination revealed right upper quadrant
pain with positive Murphy’s sign, and icteric sclerae.
Vital signs showed a body temperature of 36.5°C,
heart rate of 115/min, respiratory rate of 16/min, and
blood pressure of 160/86 mmHg. Laboratory data
showed white blood cell count of 15,700/mm3 and
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segments/lymphocytes 82.5%/7.1%, hemoglobin of
10.7 g/dL, platelet count of 312,000/mm3, blood
glucose of 196 mg/dL, alanine aminotransferase of
605 U/L, aspartate aminotransferase of 701 U/L,
total bilirubin of 2.2 mg/dL, direct bilirubin of
1.3 mg/dL, lactic dehydrogenase of 429 U/L, alka-
line phosphatase of 205 U/L, γ-glutamyltransferase
of 254 U/L, amylase of 134 mg/dL, lipase of
129 mmol/L, and C-reactive protein of 1.69 mg/dL.
Abdominal US showed positive sonographic Murphy’s
sign and a distended gallbladder with echogenic
materials in the dependent portion of the gallbladder
(Figure 1). Acalculous cholecystitis was impressed ini-
tially, and the antibiotic amoxicillin/clavulanate was
administered for 2 weeks.
The patient was placed on a regimen of nothing
per os and partial parenteral nutrition. However, tarry
stools developed 3 days later. Nasogastric tube inser-
tion with irrigation was negative for blood, and upper
gastrointestinal endoscopy only showed gastric ulcer
and duodenal erosion without active bleeding. Pro-
thrombin time, partial thromboplastin time, and plate-
let counts were within normal ranges. The bleeding
time was 6 minutes and 30 seconds. Since the patient’s
abdominal pain had worsened, percutaneous transhe-
patic gallbladder drainage (PTGBD) was performed,
and dark-colored blood was drained. Cholangiography
(Figure 2A) was performed for check-up; PTGBD
showed normal drainage without contrast extravasa-
tion, and multiple filling defects within the gallblad-
der. Non-contrast CT of the abdomen (Figure 2B)
revealed some heterogeneous materials with near blood
density in the gallbladder.
The patient felt dizzy due to hypotension (30%
reduction in his baseline blood pressure) and low level
of hemoglobin. On the premise of hemorrhaging from
the gallbladder, hemoglobin level was maintained at
10–11 g/dL by blood transfusion of packed red blood
cells. Desmopressin was intravenously administered.
The amount of dark-colored blood drained by PTGBD
was about 50 mL/day. The abdominal pain resolved
and the patient’s liver function returned to normal.
The patient began oral intake smoothly 1 week later.
He underwent elective exploratory cholecystectomy
3 weeks after PTGBD, during which dark blood clots
that filled the distended gallbladder were found
(Figure 3). Pathology (Figure 4) revealed fibrosis and
chronic inflammatory cell infiltration in the lamina
propria and muscular layer of the gallbladder wall. The
patient recovered without any surgical complications.
Discussion
Uremic patients have a high risk of bleeding due to
uremic toxins, anemia, platelet dysfunction, use of
antiplatelet or anticoagulant agents, comorbidity and
aging. However, the pathogenesis of uremic bleeding
remains unclear. Platelet dysfunction in uremic patients
includes defects in adhesion, secretion and aggrega-
tion of platelets.3 In addition, uremic substances like
urea, guanidine-succinate, parathyroid hormone, phe-
nol and tryptophan products can interfere with platelet
function in uremic patients.4
In hemodialysis patients, gastrointestinal bleeding
includes peptic ulcer disease (20–30%), gastritis (20%),
telangiectasia in the stomach, duodenum, jejunum and
colon (20–30%), and duodenitis and esophagitis.5
Gallbladder bleeding is uncommon in normal subjects.
The underlying causes of hemorrhage from the gall-
bladder have been reported to be associated with
trauma, neoplasms, rupture of aneurysms, arterioscle-
rosis, varicose veins with portal hypertension, and
coagulopathy.2,6 Gallbladder bleeding is rare even in
hemodialysis patients.
Hemorrhagic cholecystitis is an unusual disease.
Our patient had biliary colic,7 leukocytosis, abnormal
liver function, obstructive jaundice, and melena. Abdo-
minal US showed gallbladder distension with wall
thickening, and heterogeneous echogenic materials in
the dependent part. Acute acalculous cholecystitis was
diagnosed. Although CT, radioisotope imaging, and
endoscopy may help with diagnosis, US is the initial
imaging choice for intracholecystic hemorrhage. On
US, such hemorrhage manifests as intensely echogenic
mass-like lesions without acoustic shadows within the
gallbladder. Color and duplex Doppler US help to
confirm the absence of blood flow within the mass,
Figure 1. Abdominal ultrasound reveals a distended gallbladder
(9 × 3.8 cm) with echogenic material (short arrows) in the depen-
dent portion of the gallbladder. The wall thickness of the gallblad-
der was about 22 mm (thin arrow).
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making the diagnosis of gallbladder tumor highly
unlikely.8
The pathogenesis of acute acalculous cholecystitis
is an acute necroinflammatory process, and its under-
lying causes include long-term absence of oral feed-
ing, major surgery, sepsis, and burn and other critical
conditions. In critically ill patients, dehydration due to
prolonged absence of oral feeding results in calcium
salt concentration and increased viscosity in the gall-
bladder. In addition, low blood flow supply, ischemic
injury of the gallbladder and bile stasis eventually lead
to the concentration of calcium salts and necrosis of
gallbladder tissue.9 Gremmels et al2 described their
pathological findings of acute cholecystitis, showing
that intramural inflammation damaged the mucosa with
infarction and erosion. This led to microabscesses of
the gallbladder wall, mural necrosis with ulceration,
fibrinous exudates, and purulent debris within the gall-
bladder lumen. The mucosal breakdown may cause
hemorrhage into the gallbladder lumen,2 and the intra-
luminal exudates and debris may mix with blood.
In the present case, bile culture was negative for
bacteria, tuberculous bacilli and fungi. Bile cytology
also revealed no malignant cells. We therefore inferred
that the acute hemorrhagic acalculous cholecystitis in
our patient was secondary to ischemic change of the
gallbladder. Although hypotension or bleeding did
not occur during hemodialysis, low perfusion of the
gallbladder associated with the hemodynamic changes
A B
Figure 2. (A) Cholangiography reveals several filling defects (arrows) in the gallbladder and proximal bile duct. (B) Non-contrast com-
puted tomography of the abdomen reveals some heterogeneous, highly attenuated materials with near blood density (arrow) in the gall-
bladder. The catheter for percutaneous transhepatic gallbladder drainage (arrowhead) passes through the gallbladder.
A B C
Figure 3. (A) Distended gallbladder (about 10.2 × 7 cm) with mild wall thickening is noted. (B) The gallbladder is filled with dark blood
clot-like material. (C) No gall stones were found within the gallbladder.
Figure 4. This section shows gallbladder tissue with fibrosis and
chronic inflammatory cell infiltration (arrows) in the lamina pro-
pria and muscular layer. Congestion is also noted.
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during dialysis cannot be excluded. In addition, a com-
bination of heparin use in hemodialysis, uremic coag-
ulopathy and concomitant vascular disease may lead
to bleeding tendency and gallbladder hemorrhage.
Treatment for hemorrhagic acalculous cholecysti-
tis was previously exploratory cholecystectomy, but
laparoscopic cholecystectomy is now the key therapy.
However, the mortality rates (30%) for laparoscopic
cholecystectomy and open cholecystectomy are the
same.10 Poor prognosis and numerous complications
have been reported, such as postoperative hemorrhage
and hypovolemic shock.11 The difficulty of surgical
treatment for such a disease in hemodialysis patients 
is mainly due to bleeding. Our patient was initially
treated with nothing per os and partial parenteral nutri-
tion supplementation. The bleeding propensity was
corrected by blood transfusion of packed red blood
cells, desmopressin infusion and non-heparinized he-
modialysis. PTGBD further improved the clinical symp-
toms of jaundice and liver dysfunction. PTGBD in
our patient was indicated for diverting bile from the
biliary tract obstruction caused by the blood clots and
a time lag of 2 weeks for elective cholecystectomy.
In summary, hemorrhagic acalculous cholecystitis
is a rare but often fatal disease. Its risk factors include
critical illness, diabetes, malignant disease, and uremia.
In patients with a high risk for bleeding diathesis who
present with biliary colic, hematemesis, jaundice and
melena, the possibility of hemorrhagic acalculous cho-
lecystitis should be considered. Early diagnosis of this
potentially fatal condition is important to facilitate
urgent surgical treatment.
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